跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 60 条关于
“tobevibart/elebsiran”
全部
60
临床试验
3
药物
3
机构
1
资讯
53
7年前
Vir Biotechnology's Tobevibart and Elebsiran Receive FDA and EMA Designations for Chronic Hepatitis Delta Treatment
去年
Vir Biotechnology's Tobevibart and Elebsiran Show Promise in Chronic Hepatitis B Treatment
去年
Vir Biotechnology's Tobevibart and Elebsiran Show Promise in Chronic Hepatitis B Treatment
去年
Vir Biotechnology's Tobevibart and Elebsiran Combination Shows Promise in Chronic Hepatitis B Treatment
去年
Vir Biotechnology Receives Positive EU Opinion for Orphan Drug Designation of Tobevibart and Elebsiran in Chronic Hepatitis Delta
去年
Vir Biotechnology's Tobevibart and Elebsiran Combination Shows Promise in Chronic Hepatitis B Treatment
去年
EMA Supports Orphan Drug Designation for Vir's HDV Therapy
去年
Vir Biotechnology's Combination Therapy Shows Promise in Chronic Hepatitis Delta
去年
Vir Biotechnology Receives Positive EU Opinion for Orphan Drug Designation of Tobevibart and Elebsiran in Chronic Hepatitis Delta
去年
Vir Biotechnology's Combination Therapy Shows Promise in Hepatitis Delta Trial
第 1 页,共 6 页
上一页
下一页